SCHEMBL17954338

SCHEMBL17954338

COC(=O)Cc1cnc2ccc(OC)cc2c1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
HPGD P15428 4/20 0.49
CYP1A2 P05177 3/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
HTT P42858 1/20 0.49
PLA2G2A P14555 1/20 0.48
MTNR1B P49286 4/20 0.47
MTNR1A P48039 3/20 0.47
KDM4E B2RXH2 4/20 0.47
MAPT P10636 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TP53 P04637 1/20 0.45
PLA2G10 O15496 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624688 0.92 ALDH1A1 (0.50) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL16624680 0.91 ALDH1A1 (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL17954339 0.82 MTNR1A (0.49) ALDH1A1HPGDMTNR1BMTNR1AKDM4E
SCHEMBL20101355 0.77 MTNR1A (0.44) ALDH1A1HPGDMTNR1BMTNR1AKDM4E
SCHEMBL20474256 0.77 KDM4E (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL16624697 0.77 MAPT (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL27971255 0.75 KDM4E (0.48) ALDH1A1HPGDHTTKDM4EMAPT
SCHEMBL21610292 0.74 ALDH1A1 (0.49) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL20101473 0.73 ALDH1A1 (0.44) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL8784296 0.73 KDM4E (0.60) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10519446-B2 Organic compounds to treat hepatitis B virus NOVARTIS AG (CH) 2019-12-31 US disclosed
US-20160215288-A1 ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2016-07-28 US disclosed
US-20160215288-A1 ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2016-07-28 US disclosed